Business Context and Reporting Period
Company: TOP SHIPS INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2018 (Specifically covering events since February 9, 2018)
Principal Executive Offices: Maroussi, Athens, Greece
Key Financial Metrics and Capital Structure
This filing reports on a specific equity financing event rather than providing a full set of financial statements (revenue, profit, cash flow, or margins are not disclosed in this document).
- Shares Issued: 21,000,000 common shares (par value $0.01 per share).
- Total Outstanding Shares: 153,736,175 shares following the issuance.
- Remaining Capacity: Up to $8.4 million worth of shares remaining available for sale under the Second Purchase Agreement.
- Warrant Adjustments:
- Exercise Price adjusted to $0.17.
- Number of shares purchasable per Warrant adjusted to 14.66 Warrant Shares.
Material Changes
The primary material change is the execution of the "Second Purchase Agreement" with Crede Capital Group LLC (dated December 11, 2017). The Company issued and sold 21,000,000 common shares. Additionally, the issuance of Series C Convertible Preferred Shares triggered adjustments to existing Warrants, allowing holders to adopt the Variable Price of the Series C shares as the Exercise Price.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the completion of a tranche of share sales under an existing purchase agreement and details the mechanical adjustments to warrant terms resulting from recent capital activities.
Risks/Contingencies: The filing notes the existence of Variable Price Securities (Series C Convertible Preferred Shares) which impact warrant exercise terms. No specific forward-looking guidance on revenue or earnings is provided in this text.
Unusual Items: The significant dilution of outstanding shares and the adjustment of warrant terms are notable corporate actions.
Investor Verification Checklist
- Verify the total capital raised from the 21,000,000 shares issued (price per share is not explicitly stated in this text, only the remaining capacity of $8.4 million).
- Confirm the impact of the warrant adjustment (Exercise Price $0.17, 14.66 shares per warrant) on potential future dilution.
- Review the terms of the "Second Purchase Agreement" with Crede Capital Group LLC to understand the conditions for the remaining $8.4 million of share sales.
- Check the conversion terms of the Series C Convertible Preferred Shares referenced as Variable Price Securities.